REG - Irish Res Prop REIT - Appointment of Joint Corporate Broker

BarclaysAnnouncement

11/01/2022 08:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220111:nRSK9941Xa&default-theme=true

RNS Number : 9941X  Irish Residential Prop REIT PLC  11 January 2022

 

 

11 January 2022

 

 

I•RES Announces Appointment of Joint Corporate Broker

 

Irish Residential Properties REIT plc ("I•RES" or the "Company") is pleased
to announce that it has appointed Barclays Bank plc to act as its joint
corporate broker alongside J&E Davy with immediate effect.

 

 

- End -

 

For further information please contact:

 

Irish Residential Properties REIT plc

Sarah Stokes, Investor
Relations
            Tel: +353 (0) 87 296 8382

 

Margaret Sweeney, Chief Executive Officer
                        Tel: +353 (0) 1 557 0974

 

For Media Requests:

Q4PR

Gerry O'Sullivan
                                 Tel: + 353 (0) 87 259 764

 

 

 

About Irish Residential Properties REIT plc

Irish Residential Properties REIT plc (together with IRES Residential
Properties Limited, the "Group") is a growth oriented Real Estate Investment
Trust that is focused on acquiring, holding, managing and developing
investments primarily focused on private residential rental accommodations in
Ireland. The Group currently owns 3,829 apartments and houses for private
rental in Dublin and Cork with an additional 69 units due for delivery at the
end of H1 2022 under pre-purchase contracts. The Company has a further 61
units currently under construction directly on owned sites with planning
approval to develop an additional 543 residential units on its existing sites.
The Company has executed on two contracts for the acquisition of 152
residential units located in Ashbrook, Clontarf, Dublin 3 in 2 phases. It is
anticipated that the Company will acquire 108 completed units in Q1 2022. The
Company has further committed to acquire 44 apartments under a forward
purchase contract, with delivery anticipated for H2 2023. The Company's shares
are listed on Euronext Dublin. Further information in respect of the Company
can be obtained from the Company's website at www.iresreit.ie
(http://www.iresreit.ie/) .

 

Note on forward-looking information

 

This note applies if and to the extent that there are forward-looking
statements in this Announcement.

This Announcement may contain forward-looking statements, which are subject to
risks and uncertainties because they relate to expectations, beliefs,
projections, future plans and strategies, anticipated events or trends, and
similar expressions concerning matters that are not historical facts. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors, which may cause the actual results, performance or achievements
of the Company or the industry in which it operates, to be materially
different from any future results, performance or achievements expressed or
implied by such forward-looking statements. The forward-looking statements
referred to in this paragraph speak only as at the date of this Announcement.
Except as required by law or by any appropriate regulatory authority, the
Company will not undertake any obligation to release publicly any revision or
updates to these forward-looking statements to reflect future events,
circumstances, unanticipated events, new information or otherwise including in
respect of the Covid-19 pandemic, the uncertainty of its duration and impact,
and any government regulations or legislation related to it.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPBCGDBRBBDGDG